The Venture Codex Logo

The Venture Codex

Overview

Develops topical hedgehog pathway inhibitor for basal cell carcinomas.

Total Raised

$90 M

Rounds

2

Links

Verticals

Biotechnology
Medical Device
Therapeutics

Investment History

  1. Equity

    Nov 2018

    $70M

  2. Series B

    Jul 2017

    $20M

Team

Sanuj Ravindran

CEO

Ervin Epstein

Co-Founder, Medical Advisor, and Director

Jean Tang

Co-Founder and Director

Phillip Beachy

Co-Founder